CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-tyrosine kinase inhibitor via suppressing PI3K/AKT
2006 ◽
Vol 79
(2)
◽
pp. P10-P10
◽
2007 ◽
Vol 4
(1)
◽
pp. 14
◽
2007 ◽
Vol 60
(6)
◽
pp. 799-809
◽
2009 ◽
Vol 11
(7)
◽
pp. 455-459
◽
2007 ◽
Vol 62
(1)
◽
pp. 97-109
◽